Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Mikal Bailey

Physician Assistant, Medical Paducah, KY Physician Assistant

NPI 1972570596 CMS profile 11016638

2603 Kentucky Ave., Mp2, Ste. 403, Paducah, KY 42001

Open in the dashboard

General payments

$84,107

465 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Mikal Bailey of Paducah, KY is reported in the CMS Open Payments database as having received $84,107 across 465 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Physician Assistant, Medical profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $59,477 27
2024 General $5,335 23
2023 General $3,329 84
2022 General $2,924 111
2021 General $13,042 220

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mikal Bailey
  • Physician Assistant, Medical median
  • Middle half of Physician Assistant, Medical
  • National median

In program year 2025, general payments to Mikal Bailey were reported at $59,477. Among 16,675 Physician Assistant, Medical profiles paid that year, the median was $214 and the middle half received between $62 and $755.

Show as a table
Year Mikal Bailey Physician Assistant, Medical median Middle half National median
2019 $0 $61 $19–$193 $163
2020 $0 $20 $14–$64 $114
2021 $13,042 $156 $41–$563 $132
2022 $2,924 $185 $55–$649 $149
2023 $3,329 $199 $58–$717 $160
2024 $5,335 $206 $62–$740 $164
2025 $59,477 $214 $62–$755 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Neuronetics, Inc. $50,773 15 payments
  2. Janssen Pharmaceuticals, Inc $15,252 64 payments
  3. AbbVie, Inc. $6,403 67 payments
  4. Allergan Inc. $3,992 11 payments
  5. Brainsway USA Inc $2,033 2 payments
  6. Novartis Pharmaceuticals Corporation $791 60 payments
  7. Biogen, Inc. $644 18 payments
  8. Biohaven Pharmaceuticals, Inc. $601 41 payments
  9. EMD Serono, Inc. $338 22 payments
  10. Neurelis, Inc. $296 15 payments
  11. Other $2,986 150 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Debt forgiveness $49,243 1 payment
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,430 12 payments
  3. Food and Beverage $10,997 440 payments
  4. Travel and Lodging $4,187 10 payments
  5. Consulting Fee $150 1 payment
  6. Education $99 1 payment
Products named General payments · program years 2021–2025
  1. Neurostar TMS Therapy System Neurostar Tms Therapy System $49,840 10 payments
  2. SPRAVATO $15,195 61 payments
  3. UBRELVY $9,919 44 payments
  4. Brainsway Deep TMS System $1,979 1 payment
  5. NEUROSTAR TMS THERAPY SYSTEM Neurostar Tms Therapy System $933 5 payments
  6. NURTEC ODT $850 60 payments
  7. KESIMPTA Neurology $373 18 payments
  8. KESIMPTA Neuroscience $355 38 payments
  9. VALTOCO $296 15 payments
  10. TYSABRI $250 3 payments
  11. Other $3,826 205 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

257

Median for Physician Assistant: 241

Drug cost

$28,609

Median for Physician Assistant: $4,110

Branded share of claims

29.2%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Spravato Esketamine Hcl Brand 23 $26,328
Methylprednisolone Generic 43 $301
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 14 $287
Albuterol Sulfate Hfa Albuterol Sulfate Brand 11 $254
Ondansetron Odt Ondansetron Brand 13 $227
Cephalexin Generic 18 $187
Cefdinir Generic 11 $186
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 14 $150
Atorvastatin Calcium Generic 12 $137
Carvedilol Generic 16 $116

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$23,074

Of which drugs: $135

Medicare patients

182

Average age 73

Services billed

1,124

94 women, 88 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 74%
Arthritis 55%
Diabetes 31%
Depression 29%
Ischemic heart disease 27%
Chronic kidney disease 24%
COPD 23%
Cancer 20%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone sodium succinate, 5 mg J2919 Office 16 400 $76

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

3 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SPRAVATO
  • Janssen Pharmaceuticals, Inc $3,272
$3,272 23 —
KESIMPTA
  • Novartis Pharmaceuticals Corporation $66
$66 — —
VRAYLAR
  • AbbVie, Inc. $18
$18 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

465 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant, Medical in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record